111134000: Oxetacaine (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anesthetic (substance)\Local anesthetic (substance)\Amide local anesthetic (substance)\Oxetacaine

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide local anesthetic (substance)\Oxetacaine

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide local anesthetic (substance)\Oxetacaine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2153813010 Oxetacaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2154820013 Oxethazaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3482733018 Oxetacaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2606931000005113 Oxetacain da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Oxetacaine	Is a	lokalanæstetikum af amidtype	false	Inferred relationship	Some
Oxetacaine	Is a	lokalanæstetikum af amidtype	false	Inferred relationship	Some
Oxetacaine	Is a	Amide and/or amide derivative (substance)	false	Inferred relationship	Some
Oxetacaine	Is a	Local anesthetic (substance)	false	Inferred relationship	Some
Oxetacaine	Is a	Amide local anesthetic (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Product containing oxetacaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Aluminium oxide and magnesium hydroxide and oxetacaine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Oxetacaine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Oxetacaine	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Oxetacaine	Inferred relationship	Some	1
Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1
Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Oxetacaine	Inferred relationship	Some	1

This concept is not in any reference sets